Logo image
The convergence insufficiency treatment trial: Design, methods, and baseline data
Journal article   Open access   Peer reviewed

The convergence insufficiency treatment trial: Design, methods, and baseline data

Mitchell Scheiman, Lynn Mitchell, Susan Cotter, Marjean Kulp, Michael Rouse, Richard Hertle, Susanna Tamkins, Jeffrey Cooper, David Granet, Brian Mohney, …
Ophthalmic epidemiology, v 15(1), pp 24-36
01 Jan 2008
PMID: 18300086
url
https://europepmc.org/articles/pmc2782898View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Life Sciences & Biomedicine Ophthalmology Science & Technology
Objective: This report describes the design and methodology of the Convergence Insufficiency Treatment Trial (CITT), the first large-scale, placebo-controlled, randomized clinical trial evaluating treatments for convergence insufficiency (CI) in children. We also report the clinical and demographic characteristics of patients. Methods: We prospectively randomized children 9 to 17 years of age to one of four treatment groups: 1) home-based pencil push-ups, 2) home-based computer vergence/accommodative therapy and pencil push-ups, 3) off ice-based vergence/accommodative therapy with home reinforcement, 4) off ice-based placebo therapy. Outcome data on the Convergence Insufficiency Symptom Survey (CISS) score (primary outcome), near point of convergence (NPC), and positive fusional vergence were collected after 12 weeks of active treatment and again at 6 and 12 months posttreatment. Results: The CITT enrolled 221 children with symptomatic CI with a mean age of 12.0 years (SD = +2.3). The clinical profile of the cohort at baseline was 9 Delta exophoria at near (+/-4.4) and 2 Delta exophoria (+/-2.8) at distance, CISS score = 30 (+/-9.0), NPC = 14 cm (+/-7.5), and near positive fusional vergence break = 13 Delta (+/- 4.6). There were no statistically significant nor clinically relevant differences between treatment groups with respect to baseline characteristics (p > 0.05).Conclusion: Hallmark features of the study design include formal definitions of conditions and outcomes, standardized diagnostic and treatment protocols, a placebo treatment arm, masked outcome examinations, and the CISS score outcome measure. The baseline data reported herein define the clinical profile of those enrolled into the CITT.

Metrics

10 Record Views
128 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Ophthalmology
Logo image